Bone Marrow Pathology Group

Daniel Arber, MD
Daniel Arber is the Donald West and Mary Elizabeth King Professor and Chair of the Department of Pathology at the University of Chicago. Prior to moving to Chicago in 2016, he was the Ronald F. Dorfman Professor of Hematopathology at Stanford University and Vice Chair of Pathology for Clinical Services. He has authored over 300 original articles and book chapters in hematopathology and molecular diagnostics. His research interests include the evaluation of prognostic and diagnostic markers in acute myeloid leukemia. He was a senior advisor for the 2016 revision to the World Health Organization classification of hematopoietic and lymphoid neoplasms and co-chaired a combined College of American Pathologist/American Society for Hematology initiative to develop guidelines for the work up of acute leukemia patients.

Adam Bagg, MD
Adam Bagg attended Medical School at the University of the Witwatersrand in South Africa, where he also completed his Pathology training in Laboratory Hematology /Hematopathology. He spent a decade at Georgetown University in Washington DC, where he repeated residency/fellowship training and subsequently joined the faculty, ultimately as Director of Hematopathology. Currently, Dr. Bagg is a Professor of Pathology and Laboratory Medicine at the University of Pennsylvania, where he is Director of Hematology, and the Hematopathology Laboratory. For the past 11 years (2010-2020), he was voted by his peers as one of Philadelphia’s “Top Doctors” (as the only hematopathologist so noted). He was elected to Council/Board of Directors of USCAP for a 4-year term in 2011. Dr. Bagg has lectured extensively nationally (including at USCAP, ASCP, AMP, CAP, ACLPS, AACC, ISLH and ASH) and internationally (21 countries). He has over 200 publications, including peer-reviewed articles, invited reviews and textbook chapters, most in the realm of the molecular pathology of hematologic malignancies. He is an Associate Editor (for Hematopathology) of the Journal of Molecular Diagnostics and on the Editorial Board of Advances in Anatomic Pathology.

Carlos Bueso-Ramos, MD, PhD
Dr. Carlos Bueso-Ramos is a Professor in the Department of Hematopathology and Section Chief of the Diagnostic Bone Marrow Laboratory at The University of Texas MD Anderson Cancer Center, where he also serves as a Faculty member in the Diagnostic Genetics Program at the UT School of Health Professions. He received his MD from the Universidad Autonoma in Honduras and his PhD from Emory University School of Medicine, where he also completed his AP/CP Residency Training as well. He completed his Surgical Pathology and Hematopathology training at MD Anderson Cancer Center. Dr. Bueso-Ramos served as a Member of the Clinical Advisory Committee for the Revision to the 4th edition of the WHO Classification of Haematopoietic and Lymphoid Neoplasms. His interests include apoptosis and proliferation in leukemias and factors that affect the regulation of cell lineage determination, maturation arrest and transformation in leukemia. His current studies focus on hematopoietic cytokines and DNA binding proteins that regulate the NF-kB and p53 pathways.

Kathy Foucar, MD
Dr. Foucar received her BS and MD degrees from Ohio State University, Columbus, Ohio, and her specialty training in AP/CP at the University of New Mexico and the University of Minnesota. She completed a surgical pathology fellowship at the University of Minnesota. She has over 40 years of practice in diagnostic hematopathology, and is the co-founder of the Hematopathology Fellowship at UNM. She is a Distinguished Professor of Pathology Emerita at the University of New Mexico Health Sciences Center. She is the author/co-author or editor of thirteen books on neoplastic and non-neoplastic hematopathology with an emphasis on blood and bone marrow, and over 120 peer-reviewed publications. She is the 2019 recipient of the Alumni Achievement Award from Ohio State University School of Medicine.

Tracy I. George, MD
Dr. Tracy George is Chief Medical Officer at ARUP Laboratories and Professor of Pathology at the University of Utah. Prior to moving to Utah in 2018, Dr. George was Vice Chair of Clinical Affairs, Hematopathology Division Chief, and the Hematopathology Fellowship Director at the University of New Mexico. Dr. George received her medical degree from the University of California San Francisco School of Medicine, where she completed a residency in Pathology and Laboratory Medicine. She completed her specialty training in Hematopathology and Surgical Pathology at Stanford University School of Medicine, where she was also a faculty member for a decade. Dr. George is President for the International Society for Laboratory Hematology (ISLH) and previously served as Editor-in-Chief for the International Journal of Laboratory Hematology. She has authored more than 130 peer reviewed publications, and lectured around the world at various conferences including the American Society of Hematology, the College of American Pathologists (CAP), the European Competence Network on Mastocytosis, the United States and Canadian Academy of Pathology, and ISLH. Her research interests are in laboratory hematology and the pathology of myeloid neoplasms, specifically mast cell disease. Dr. George received the CAP Lifetime Achievement Award in 2014.

Robert Hasserjian, MD
Dr. Robert Hasserjian is a Professor of Pathology at Massachusetts General Hospital and Harvard Medical School, where he is Director of the Hematopathology Fellowship and is an Associate Director of the Pathology Residency Program. Dr Hasserjian received his MD from Harvard in 1990 and trained in Anatomic Pathology and Hematopathology at Brigham and Women's Hospital. Dr Hasserjian is a Senior Reviewer for the update to the 4th edition of the WHO Classification of Myeloid Neoplasms and is currently the Secretary/Treasurer of the Society for Hematopathology. His research interests are in the discovery of pathologic and genetic features associated with the biologic behavior of myeloid and lymphoid neoplasms.

Eric Hsi, MD
Eric Hsi, is a Professor of Pathology and Chair of the Department of Pathology at Wake Forest School of Medicine. Dr. Hsi received his MD degree and did his AP/CP and hematopathology training at the University of Michigan. He is an expert in diagnosis and classification of hematologic malignancy with interests in immunophenotyping and molecular hematopathology. His research interests include pre-clinical therapeutic assessment and biomarkers in lymphoma and leukemia. He has authored over 350 peer-reviewed manuscripts, edited a textbook in Hematopathology, serves on several editorial boards, and has held committee leadership positions for the College of American Pathologists, ALLIANCE, and American Society for Hematology.

Attilio Orazi, MD
Attilio Orazi M.D., FRCPath. (Engl.) is Tenured Professor and Chair of the Department of Pathology at Texas Tech Health Sciences Center El Paso, Texas. He has published more than 270 articles and more than 30 book chapters. He is first, lead or co-author of four textbooks: Knowles’ Neoplastic Hematopathology; Illustrated Pathology of the Bone Marrow; Benign and Reactive Conditions of Lymph Node and Spleen; and Disorders of the Spleen. He was a Senior Advisor for the 2016 update of the 4th edition of the WHO Classification of Tumors of the Hematopoietic and Lymphoid Tissues. He is a member of several editorial boards. His research interests include diagnostic integration and prognostic assessment in bone marrow and spleen pathology.